Join the Asthma group to help and get support from people like you.
Asthma News (Page 9)
Related terms: Bronchial Asthma, Exercise-induced asthma, Wheezing
FDA Approves Nucala (mepolizumab) to Treat Severe Asthma
November 4, 2015 - The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and...
FDA Approves Spiriva Respimat (tiotropium) for Maintenance Treatment of Asthma in Adults and Adolescents
RIDGEFIELD, Conn., September 16, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat for the long-term, o...
FDA Approves Breo Ellipta (fluticasone furoate/vilanterol) for Asthma
London, UK, and South San Francisco, CA, USA, 30 April 2015 – GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has a...
Teva Announces FDA Approval of ProAir RespiClick
JERUSALEM--(BUSINESS WIRE)--Apr. 1, 2015-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol...
FDA Medwatch Alert: Over-the-Counter Asthma Products Labeled as Homeopathic: FDA Statement - Consumer Warning About Potential Health Risks
ISSUE: FDA is warning consumers not to rely on asthma products labeled as homeopathic that are sold over-the-counter (OTC). These products have not been evaluated by the FDA for safety and e...
FDA Medwatch Alert: Xolair (omalizumab): Drug Safety Communication - Slightly Elevated Risk of Cardiovascular and Cerebrovascular Serious Adverse Events
ISSUE: An FDA review of safety studies suggests a slightly increased risk of problems involving the heart and blood vessels supplying the brain among patients being treated with the asthma drug...
FDA Approves Arnuity Ellipta (fluticasone furoate) for the Treatment of Asthma
20 August 2014 – GlaxoSmithKline plc today announced that the Food and Drug Administration has approved Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid...
FDA Medwatch Alert: Albuterol Sulfate Inhalation Solution, 0.083 percent (Nephron Pharmaceuticals): Recall - Aseptic Processing Simulation Results
ISSUE: Nephron Pharmaceuticals initiated a voluntary recall, at the retail level, of ten lots of product due to results from an internal monitoring process. NPC performs aseptic process simulation...
Horizon Pharma Announces FDA Approval of Rayos (prednisone) Delayed-Release Tablets for Rheumatoid Arthritis and Multiple Additional Indications
DEERFIELD, Ill., July 26, 2012 /PRNewswire/ – Horizon Pharma, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Rayos (prednisone) delayed-release tablets (1 mg, 2...
FDA Approves Merck's Dulera (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Jun 24, 2010 - Merck today announced that the U.S. Food and Drug Administration (FDA) has approved Dulera (mometasone furoate and formoterol fumarate...
FDA Medwatch Alert: Unapproved Compounded Inhalation Drugs
[Posted 08/10/2006] The FDA notified consumers and healthcare professionals that RoTech Healthcare, Inc., CCS Medical, and Reliant Pharmacy Services are manufacturing and distributing unapproved...
Further information
Related condition support groups
Asthma - Maintenance, Asthma - Acute
Related drug support groups
prednisone, methylprednisolone, albuterol, caffeine, triamcinolone, Dupixent, Medrol, Xolair, dexamethasone, view more... Trelegy Ellipta, fluticasone, omalizumab, montelukast, budesonide, dupilumab